PLTR analyst scorecard · Palantir Technologies
64 rating actions on PLTR in the last 12 months. Of 82 price targets that resolved, 30 were reached while they stood, 51 were replaced by the same firm first, and 1 fell short at their deadline. Ratings: 75% Buy-type, 22% Hold-type, 3% Sell-type. Consensus target $211, 9% above the last close.
Checked through 2026-10-29 · last close $193.34 (2026-10-29). Rebuilt every morning.
What the Holds say: 13 Hold-type ratings on PLTR in the last 12 months carried a median target +8% from the price on the day; 15% sat below it.
The 9 upgrades on PLTR came after an average -5.6% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Rosenblatt | Buy | 2026-10-27 | $260 | 0 | 10 | 10 | — |
| Citigroup | Buy | 2026-10-22 | $250 | 1 | 6 | 7 | — |
| UBS | Buy | 2026-09-15 | $250 | 1 | 5 | 6 | — |
| DA Davidson | Buy | 2026-09-11 | $250 | 2 | 8 | 10 | — |
| Wedbush | Outperform | 2026-06-05 | $230 | 4 | 0 | 4 | 1 of 1 |
| Oppenheimer | Outperform | 2026-10-29 | $235 | 1 | 0 | 1 | — |
| Freedom Broker | Buy | 2026-02-13 | $170 | 1 | 0 | 1 | — |
| Deutsche Bank | Buy | 2026-08-04 | $200 | 2 | 0 | 2 | — |
| Wolfe Research | Peer Perform | 2026-06-16 | — | — | — | 0 | — |
| Argus Research | Buy | 2026-05-06 | $190 | 1 | 0 | 1 | — |
| Mizuho | Outperform | 2026-10-15 | $245 | 1 | 8 | 9 | — |
| Piper Sandler | Overweight | 2026-10-23 | $231 | 4 | 2 | 6 | 0 of 1 |
| RBC Capital | Underperform | 2026-05-05 | $90 | 0 | 2 | 2 | 0 of 1 |
| Goldman Sachs | Buy | 2026-10-08 | $230 | 0 | 3 | 3 | — |
| Cantor Fitzgerald | Neutral | 2026-08-04 | $156 | 2 | 0 | 2 | — |
| Barclays | Overweight | 2026-10-09 | $265 | — | — | 0 | — |
| HSBC | Hold | 2026-05-01 | $151 | — | — | 0 | — |
| Phillip Securities | Buy | 2026-01-22 | $208 | 1 | 0 | 1 | — |
| Truist Securities | Buy | 2026-01-06 | $223 | — | — | 0 | — |
| Morgan Stanley | Equal-Weight | 2025-11-04 | $205 | 3 | 1 | 4 | — |
| Baird | Neutral | 2025-11-04 | $200 | — | — | 0 | — |
| Bank of America | Buy | 2025-11-04 | $255 | 2 | 1 | 3 | 1 of 1 |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor PLTR carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | Oppenheimer | Outperform | reiterated | $193.34 | $235 | running to 2027-10-29 | +3.4% |
| 2026-10-27 | Rosenblatt | Buy | maintained | $198.73 | $260 | running to 2027-10-27 | +4.8% |
| 2026-10-23 | Piper Sandler | Overweight | maintained | $196.75 | $231 | running to 2027-10-23 | +2.6% |
| 2026-10-22 | Citigroup | Buy | maintained | $196.19 | $250 | running to 2027-10-22 | +6.0% |
| 2026-10-15 | Mizuho | Outperform | maintained | $200.50 | $245 | running to 2027-10-15 | +16.2% |
| 2026-10-09 | Barclays | Overweight | initiated | $209.05 | $265 | running to 2027-10-09 | +23.3% |
| 2026-10-08 | Goldman Sachs | Neutral → Buy | upgrade | $198.78 | $230 | running to 2027-10-08 | +16.7% |
| 2026-09-23 | Rosenblatt | Buy | maintained | $191.79 | $225 | replaced 2026-10-27, new $260 | +9.0% |
| 2026-09-15 | UBS | Buy | maintained | $172.56 | $250 | running to 2027-09-15 | -0.8% |
| 2026-09-11 | DA Davidson | Buy | maintained | $167.23 | $250 | running to 2027-09-11 | -2.2% |
| 2026-09-11 | Rosenblatt | Buy | maintained | $167.23 | $225 | replaced 2026-10-27, new $260 | -2.2% |
| 2026-08-04 | UBS | Buy | maintained | $162.66 | $220 | replaced 2026-09-15, new $250 | +25.8% |
| 2026-08-04 | Mizuho | Outperform | maintained | $162.66 | $215 | replaced 2026-10-15, new $245 | +25.8% |
| 2026-08-04 | Citigroup | Buy | maintained | $162.66 | $245 | replaced 2026-10-22, new $250 | +25.8% |
| 2026-08-04 | DA Davidson | Buy | maintained | $162.66 | $200 | replaced 2026-09-11, new $250 | +25.8% |
| 2026-08-04 | Cantor Fitzgerald | Neutral | maintained | $162.66 | $156 | within 5% of price when set | +25.8% |
| 2026-08-04 | Rosenblatt | Buy | maintained | $162.66 | $225 | replaced 2026-10-27, new $260 | +25.8% |
| 2026-08-04 | Deutsche Bank | Hold → Buy | upgrade | $162.66 | $200 | reached 2026-10-09 | +25.8% |
| 2026-08-04 | Piper Sandler | Overweight | reiterated | $162.66 | $230 | replaced 2026-10-23, new $231 | +25.8% |
| 2026-07-30 | Rosenblatt | Buy | maintained | $122.26 | $225 | replaced 2026-10-27, new $260 | +4.8% |
| 2026-07-24 | Citigroup | Buy | maintained | $122.92 | $200 | replaced 2026-08-04, new $245 | +8.3% |
| 2026-07-17 | DA Davidson | Buy | maintained | $132.38 | $175 | replaced 2026-08-04, new $200 | +1.3% |
| 2026-07-02 | DA Davidson | Neutral → Buy | upgrade | $129.30 | $175 | replaced 2026-08-04, new $200 | -15.0% |
| 2026-06-16 | Wolfe Research | Underperform → Peer Perform | upgrade | $133.25 | — | no target | -0.6% |
| 2026-06-05 | Rosenblatt | Buy | maintained | $135.53 | $225 | replaced 2026-10-27, new $260 | +1.3% |
| 2026-06-05 | Wedbush | Outperform | reiterated | $135.53 | $230 | running to 2027-06-05 | +1.3% |
| 2026-05-21 | Rosenblatt | Buy | maintained | $137.41 | $225 | replaced 2026-10-27, new $260 | -5.9% |
| 2026-05-06 | Citigroup | Buy | maintained | $133.79 | $225 | replaced 2026-07-24, new $200 | -9.6% |
| 2026-05-06 | Argus Research | Hold → Buy | upgrade | $133.79 | $190 | reached 2026-09-23 | -9.6% |
| 2026-05-05 | RBC Capital | Underperform | reiterated | $135.91 | $90 | running to 2027-05-05 | -8.4% |
| 2026-05-05 | Wedbush | Outperform | reiterated | $135.91 | $230 | running to 2027-05-05 | -8.4% |
| 2026-05-05 | DA Davidson | Neutral | maintained | $135.91 | $165 | replaced 2026-07-02, new $175 | -8.4% |
| 2026-05-05 | Rosenblatt | Buy | maintained | $135.91 | $225 | replaced 2026-10-27, new $260 | -8.4% |
| 2026-05-01 | HSBC | Buy → Hold | downgrade | $144.07 | $151 | within 5% of price when set | -1.6% |
| 2026-04-30 | Oppenheimer | Outperform | initiated | $139.11 | $200 | reached 2026-10-09 | -4.9% |
| 2026-04-28 | Citigroup | Buy | maintained | $141.18 | $210 | replaced 2026-05-06, new $225 | -1.3% |
| 2026-04-16 | DA Davidson | Neutral | maintained | $142.76 | $180 | replaced 2026-05-05, new $165 | -7.9% |
| 2026-04-14 | Mizuho | Outperform | maintained | $135.70 | $185 | replaced 2026-08-04, new $215 | -10.1% |
| 2026-04-10 | Wedbush | Outperform | reiterated | $128.06 | $230 | running to 2027-04-10 | -15.5% |
| 2026-03-25 | Rosenblatt | Buy | maintained | $154.96 | $200 | replaced 2026-05-05, new $225 | +18.6% |
| 2026-03-18 | UBS | Buy | maintained | $152.77 | $200 | replaced 2026-08-04, new $220 | +16.2% |
| 2026-03-16 | Wedbush | Outperform | reiterated | $152.72 | $230 | running to 2027-03-16 | +16.2% |
| 2026-03-03 | Rosenblatt | Buy | maintained | $147.22 | $200 | replaced 2026-05-05, new $225 | +0.4% |
| 2026-02-27 | Rosenblatt | Buy | initiated | $137.19 | $150 | replaced 2026-03-03, new $200 | -12.8% |
| 2026-02-26 | UBS | Neutral → Buy | upgrade | $135.94 | $180 | replaced 2026-03-18, new $200 | -18.0% |
| 2026-02-18 | Mizuho | Neutral → Outperform | upgrade | $135.38 | $195 | replaced 2026-04-14, new $185 | -20.8% |
| 2026-02-13 | Freedom Broker | Sell → Buy | upgrade | $131.41 | $170 | reached 2026-08-07 | -26.3% |
| 2026-02-03 | DA Davidson | Neutral | maintained | $157.88 | $180 | replaced 2026-05-05, new $165 | -6.0% |
| 2026-02-03 | Citigroup | Buy | maintained | $157.88 | $260 | replaced 2026-04-28, new $210 | -6.0% |
| 2026-02-03 | UBS | Neutral | maintained | $157.88 | $180 | replaced 2026-03-18, new $200 | -6.0% |
| 2026-01-22 | Phillip Securities | Buy | initiated | $165.90 | $208 | reached 2026-10-09 | -14.5% |
| 2026-01-12 | Citigroup | Neutral → Buy | upgrade | $179.41 | $235 | replaced 2026-02-03, new $260 | -2.3% |
| 2026-01-06 | Truist Securities | Buy | initiated | $179.71 | $223 | running to 2027-01-06 | -1.1% |
| 2025-11-13 | Freedom Broker | Buy | maintained | $172.14 | $170 | within 5% of price when set | — |
| 2025-11-04 | DA Davidson | Neutral | maintained | $190.74 | $215 | replaced 2026-02-03, new $180 | — |
| 2025-11-04 | Morgan Stanley | Equal-Weight | maintained | $190.74 | $205 | reached 2026-10-09 | — |
| 2025-11-04 | Goldman Sachs | Neutral | maintained | $190.74 | $188 | within 5% of price when set | — |
| 2025-11-04 | Baird | Neutral | maintained | $190.74 | $200 | within 5% of price when set | — |
| 2025-11-04 | RBC Capital | Underperform | maintained | $190.74 | $50 | — | — |
| 2025-11-04 | UBS | Neutral | maintained | $190.74 | $205 | replaced 2026-02-03, new $180 | — |
| 2025-11-04 | Cantor Fitzgerald | Neutral | maintained | $190.74 | $198 | within 5% of price when set | — |
| 2025-11-04 | Piper Sandler | Overweight | maintained | $190.74 | $225 | replaced 2026-08-04, new $230 | — |
| 2025-11-04 | Mizuho | Neutral | maintained | $190.74 | $205 | replaced 2026-02-18, new $195 | — |
| 2025-11-04 | Bank of America | Buy | maintained | $190.74 | $255 | running to 2026-11-04 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.